Patient immobilization was carried out using a ProStepTM pelvic and lower extremity support (Elekta, Stockholm, Sweden). No patient received implanted fiducials prior to radiotherapy. The clinical target volume (CTV) covered the prostate gland for low-risk tumors and also the base of the seminal vesicles for intermediate-risk cancers. The planning target volume (PTV) comprised an additional 7 mm as a setup margin. Treatment plans were generated based on the hypofractionated arm of the CHHiP trial to a total dose of 60 Gy in 20 fractions of 3 Gy (7 (link)). Dose constraints to the organs-at risk (OARs) were defined in accordance with the Quantitative Analyses of Normal Tissue Effects in the Clinic (21 (link)–23 (link)). Treatment plans for a step-and-shoot IMRT using 9 co-planar fields were generated on the RayStation planning system (RaySearch Laboratories, Stockholm, Sweden). All patients were instructed to present to each treatment fraction with a comfortably filled bladder and an empty rectum.
Free full text: Click here